Norges Bank’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,132
| Closed | -$1.7M | – | 1993 |
|
|
2023
Q2 | $1.7M | Hold |
25,132
| – | – | ﹤0.01% | 1884 |
|
|
2023
Q1 | $11.7M | Sell |
25,132
-6,432
| -20% | -$3.4M | ﹤0.01% | 1513 |
|
|
2022
Q4 | $12.6M | Hold |
31,564
| – | – | ﹤0.01% | 1482 |
|
|
2022
Q3 | $10.3M | Hold |
31,564
| – | – | ﹤0.01% | 1528 |
|
|
2022
Q2 | $8.33M | Buy |
31,564
+1,067
| +3% | +$273K | ﹤0.01% | 1626 |
|
|
2022
Q1 | $9.16M | Buy |
30,497
+4,797
| +19% | +$1.67M | ﹤0.01% | 1734 |
|
|
2021
Q4 | $9.06M | Sell |
25,700
-1,103
| -4% | -$343K | ﹤0.01% | 1791 |
|
|
2021
Q3 | $6.85M | Buy |
26,803
+8,713
| +48% | +$3.09M | ﹤0.01% | 1861 |
|
|
2021
Q2 | $12M | Buy |
18,090
+8,260
| +84% | +$4.76M | ﹤0.01% | 1724 |
|
|
2021
Q1 | $8.53M | Sell |
9,830
-18,874
| -66% | -$20.1M | ﹤0.01% | 1821 |
|
|
2020
Q4 | $26.6M | Sell |
28,704
-1,635
| -5% | -$1.72M | 0.01% | 1396 |
|
|
2020
Q3 | $31.2M | Sell |
30,339
-1,974
| -6% | -$2.12M | 0.01% | 1141 |
|
|
2020
Q2 | $32.7M | Sell |
32,313
-1,612
| -5% | -$1.5M | 0.01% | 1131 |
|
|
2020
Q1 | $29.5M | Buy |
33,925
+3,936
| +13% | +$3.91M | 0.01% | 988 |
|
|
2019
Q4 | $32.2M | Hold |
29,989
| – | – | 0.01% | 1214 |
|
|
2019
Q3 | $27.7M | Hold |
29,989
| – | – | 0.01% | 1263 |
|
|
2019
Q2 | $33.9M | Sell |
29,989
-761
| -2% | -$833K | 0.01% | 1141 |
|
|
2019
Q1 | $41.8M | Buy |
30,750
+2,570
| +9% | +$3.49M | 0.01% | 974 |
|
|
2018
Q4 | $32.6M | Buy |
28,180
+1,053
| +4% | +$1.18M | 0.01% | 1061 |
|
|
2018
Q3 | $41.2M | Buy |
27,127
+615
| +2% | +$947K | 0.01% | 1011 |
|
|
2018
Q2 | $41.5M | Sell |
26,512
-1,104
| -4% | -$1.44M | 0.01% | 981 |
|
|
2018
Q1 | $31.9M | Buy |
27,616
+1,015
| +4% | +$1.34M | 0.01% | 1101 |
|
|
2017
Q4 | $31.5M | Sell |
26,601
-888
| -3% | -$1.11M | 0.01% | 1141 |
|
|
2017
Q3 | $37M | Buy |
27,489
+10,658
| +63% | +$11.2M | 0.01% | 987 |
|
|
2017
Q2 | $13.6M | Buy |
16,831
+980
| +6% | +$683K | 0.01% | 1630 |
|
|
2017
Q1 | $9.77M | Hold |
15,851
| – | – | ﹤0.01% | 1745 |
|
|
2016
Q4 | $8.48M | Buy |
15,851
+2,624
| +20% | +$1.31M | ﹤0.01% | 1743 |
|
|
2016
Q3 | $6.54M | Buy |
13,227
+334
| +3% | +$157K | ﹤0.01% | 1816 |
|
|
2016
Q2 | $5.29M | Hold |
12,893
| – | – | ﹤0.01% | 1860 |
|
|
2016
Q1 | $6.86M | Hold |
12,893
| – | – | ﹤0.01% | 1726 |
|
|
2015
Q4 | $9.82M | Buy |
12,893
+8,662
| +205% | +$5.75M | ﹤0.01% | 1597 |
|
|
2015
Q3 | $2.32M | Buy |
+4,231
| New | +$2.56M | ﹤0.01% | 2015 |
|
Other funds holding KYNB
AC
Norges Bank's KYNB Position: Q3 2023 in Review
Norges Bank sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 25,132 shares — an estimated $1.7M sold.
Norges Bank first reported a position in KYNB in Q3 2015 and held it in 32 quarters. The position peaked at $41.8M in Q1 2019. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.
- Norges Bank reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
- Norges Bank sold 25,132 Kyntra Bio shares in Q3 2023, an estimated $1.7M.
- Norges Bank first reported a position in Kyntra Bio in Q3 2015 and held it in 32 quarters.
- Norges Bank's Kyntra Bio position peaked at $41.8M in Q1 2019.
- 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.
Based on Norges Bank's 13F filing for Q3 2023, filed 13 Nov 2023.